Publication Name	World Journal of Gastroenterology
Manuscript ID	21905
Country	Canada

Received	2015-07-31 09:51
Peer-Review Started	2015-07-31 11:50
To Make the First Decision	2015-08-31 08:31
Return for Revision	2015-09-06 16:38
Revised	2015-09-20 02:53
Second Decision	2015-11-11 16:57
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2015-11-24 16:53
Articles in Press	2015-11-24 16:53
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-12-29 10:26
Publish the Manuscript Online	2016-01-20 16:55

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Review
Article Title	Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon
Manuscript Source	Invited Manuscript
All Author List	Sara Belga and Karen Elizabeth Doucette
Funding Agency and Grant Number
Corresponding Author	Karen Elizabeth Doucette, MD, MSc, Division of Infectious Diseases, Department of Medicine, University of Alberta, 11350 83 Avenue, Clinical Sciences Building 1-139, Edmonton, Alberta T6G 2G3, Canada. karen.doucette@ualberta.ca
Key Words	Hepatitis C; chronic; Kidney transplantation; Heart transplantation; Lung transplantation; Liver trans­plantation; Kidney failure; Chronic; Antiviral agents
Core Tip	Direct acting antiviral (DAA) therapy has the potential to eliminate hepatitis C virus (HCV) from the population of organ transplant candidates and recipients and thereby the negative impact of HCV on outcomes. Among non-hepatic organ transplant patients, the biggest barriers currently are limited safety and efficacy data in this population, particularly in those with advanced renal disease, and global variability of access and reimbursement for DAAs. Future research is needed to better assess safety, efficacy and impact of DAA therapy in non-hepatic solid organ transplant, as well as to explore the safety of using HCV infected donors, with prophylactic therapy, to expand the donor pool.
Publish Date	2016-01-20 16:55
Citation	Belga S, Doucette KE. Hepatitis C in non-hepatic solid organ transplant candidates and recipients: A new horizon. World J Gastroenterol 2016; 22(4): 1650-1663
URL	http://www.wjgnet.com/1007-9327/full/v22/i4/1650.htm
DOI	http://dx.doi.org/10.3748/wjg.v22.i4.1650

Full Article (PDF)	WJG-22-1650.pdf
Full Article (Word)	WJG-22-1650.doc
Manuscript File	21905-Review.docx
Answering Reviewers	21905-Answering reviewers.pdf
Audio Core Tip	21905-Audio core tip.wav
Conflict-of-Interest Disclosure Form	21905-Conflict of interest statement.pdf
Copyright License Agreement	21905-Copyright assignment.pdf
Peer-review Report	21905-Peer-review(s).pdf
Scientific Misconduct Check	21905-Scientific misconduct check.pdf
Scientific Editor Work List	21905-Scientific editor work list.pdf